-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $9.5

Benzinga·07/09/2026 13:19:51
Listen to the news
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight and raises the price target from $9 to $9.5.